Etrasimod Significantly Benefits Ulcerative Colitis Regardless of Corticosteroids; New data from ACG 2023 shows etrasimod-treated patients were able to achieve UC remission, with or without concomitant steroid treatment at baseline.

Press/Media

Period26 Oct 2023 → 27 Oct 2023

Media coverage

2

Media coverage

  • TitleEtrasimod Significantly Benefits Ulcerative Colitis Regardless of Corticosteroids; New data from ACG 2023 shows etrasimod-treated patients were able to achieve UC remission, with or without concomitant steroid treatment at baseline.
    Media name/outletConsultant Live
    Country/TerritoryUnited States
    Date27/10/23
    PersonsBruce E. Sands
  • TitleEtrasimod Significantly Benefits Ulcerative Colitis Regardless of Corticosteroids
    Media name/outletHCP Live
    Country/TerritoryUnited States
    Date26/10/23
    PersonsBruce E. Sands